WST Financial Facts

Gross profit: 121.1M
Cost of goods and services sold: 255.6M
See Full Income Statement

Accounts receivable, net: 209.5M
Investments in affiliated companies: 81.4M
See Full Balance Sheet

West Pharmaceutical Services, Inc. (WST) Earnings

  |   Expand Research on WST
Next EPS Date 7/23/21 *Est. EPS Growth Rate +103.0% *Last Qtr.
Average EPS % Beat Rate +29.1% Revenue Growth Rate +36.5% *Last Qtr.
Average % Move 1-Wk after EPS -0.2% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
4/29/21 Q121 $2.05$1.43 +$0.62$670.7M$611.39M = Details
2/18/21 Q420 $1.34$1.12 +$0.22$580.2M$543.67M = Details
10/22/20 Q320 $1.15$0.99 +$0.16$548M$510.14M = Details
7/23/20 Q220 $1.25$0.91 +$0.34$527.2M$496.09M = Details
4/23/20 Q120 $1.01$0.82 +$0.19$491.5M$466.79M = Details
2/13/20 Q419 $0.82$0.72 +$0.10$470.6M$451.53M = Details
10/24/19 Q319 $0.79$0.71 +$0.08$456.1M$450.94M = Details
7/25/19 Q219 $0.89$0.72 +$0.17$469.7M$460.4M = Details